Breakthrough Technology & Novel Solutions

We will apply proprietary nano medical engineering technologies for detection and treatment of cancer diseases.
We plan to utilize off-the-shelf AI tools to help refine inputs to the invitro study, preclinical and clinical studies, to enable greater than 95% confidence intervals in Nanobomb Plus’s ability to selectively kill cancer cells but without impacting on study cost.
We have filed provisional patent applications to protect our IPs globally. Patent protection will focus particularly for Australia, US, EU, China including Hong Kong and Macau SARs, Japan, Indian sub-continent, and the African Union of Nations.
Our comparable advantage is the offer of non-toxic non invasive nano medical engineering treatment combined with immunotherapy with much improved efficacy and reduced side effects, compared to systemic chemotherapy, radiation therapy, nuclear treatment, and surgery.

Breakthrough technology and novel solutions